AN OPEN LABEL, SINGLE ARM, PHASE I/II STUDY TO ASSESS THE SAFETY AND EFFICACY OF PERIANAL ADMINISTRATION OF STEMPEUCEL® (ADULT HUMAN BONE MARROW DERIVED, CULTURED, POOLED, ALLOGENEIC MESENCHYMAL STROMAL CELLS) IN PATIENTS WITH PERIANAL FISTULIZING CROHN'S DISEASE

被引：0

作者：

Gupta, P. K. ^{[1
]}

Kumar, U. ^{[1
]}

Shanmugam, S. Subramanian ^{[1
]}

Swaroop, S. ^{[2
]}

Ahuja, V. ^{[2
]}

机构：

[1] Stempeut Res, Bangalore, Karnataka, India

[2] All India Inst Med Sci, Dept Gastroenterol, New Delhi, India

来源：

CYTOTHERAPY | 2024年 / 26卷 / 06期

关键词：

Perianal fistuala due to Crohn's disease; Stempeucel; Mesenchymal stromal cells;

D O I：

暂无

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

引用

页码：S22 / S23

页数：2

共 48 条

[41] Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study
Adrian J. C. Bloor
Amit Patel
James E. Griffin
Maria H. Gilleece
Rohini Radia
David T. Yeung
Diana Drier
Laurie S. Larson
Gene I. Uenishi
Derek Hei
Kilian Kelly
Igor Slukvin
John E. J. Rasko
Nature Medicine, 2020, 26 : 1720 - 1725
[42] Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study
Bloor, Adrian J. C.
Patel, Amit
Griffin, James E.
Gilleece, Maria H.
Radia, Rohini
Yeung, David T.
Drier, Diana
Larson, Laurie S.
Uenishi, Gene I.
Hei, Derek
Kelly, Kilian
Slukvin, Igor
Rasko, John E. J.
NATURE MEDICINE, 2020, 26 (11) : 1720 - +
[43] Evaluation of amnion-derived mesenchymal stem cells for treatment-resistant moderate Crohn's disease: study protocol for a phase I/II, dual-centre, open-label, uncontrolled, dose-response trial
Otagiri, Shinsuke
Ohnishi, Shunsuke
Miura, Arisa
Hayashi, Hiroshi
Kumagai, Izumi
Ito, Yoichi M.
Katsurada, Takehiko
Nakamura, Shiro
Okamoto, Rika
Yamahara, Kenichi
Cho, Kyu Yong
Isoe, Toshiyuki
Sato, Norihiro
Sakamoto, Naoya
BMJ OPEN GASTROENTEROLOGY, 2018, 5 (01):
[44] Safety and efficacy of intracoronary artery administration of human bone marrow-derived mesenchymal stem cells in STEMI of Lee-Sung pigs-A preclinical study for supporting the feasibility of the OmniMSC-AMI phase I clinical trial
Chen, Wannhsin
Hou, Chun-Hsiang
Chen, Yi-Ling
Shen, Hsin-Hsin
Lin, Chen-Hsuan
Wu, Cheng-Yi
Lin, Meng-Hsueh
Liao, Chih-Ching
Huang, Jun-Jae
Yang, Chi-Yu
Li, Yi-Chen
Yip, Hon-Kan
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
[45] Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)
Soria-Juan, Barbara
Garcia-Arranz, Mariano
Llanos Jimenez, Lucia
Aparicio, Cesar
Gonzalez, Alejandro
Mahillo Fernandez, Ignacio
Riera del Moral, Luis
Grochowicz, Lukasz
Andreu, Enrique J.
Marin, Pedro
Castellanos, Gregorio
Moraleda, Jose Maria
Garcia-Hernandez, Ana Maria
Lozano, Francisco S.
Sanchez-Guijo, Fermin
Villaron, Eva Maria
Parra, Miriam Lopez
Yanez, Rosa Maria
de la Cuesta Diaz, Antonio
Tejedo, Juan Rigoberto
Bedoya, Francisco J.
Martin, Franz
Miralles, Manuel
del Rio Sola, Lourdes
Fernandez-Santos, Maria Eugenia
Ligero, Jose Manuel
Morant, Francisco
Hernandez-Blasco, Luis
Andreu, Etelvina
Hmadcha, Abdelkrim
Garcia-Olmo, Damian
Soria, Bernat
TRIALS, 2021, 22 (01)
[46] Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)
Barbara Soria-Juan
Mariano Garcia-Arranz
Lucía Llanos Jiménez
César Aparicio
Alejandro Gonzalez
Ignacio Mahillo Fernandez
Luis Riera del Moral
Lukasz Grochowicz
Enrique J. Andreu
Pedro Marin
Gregorio Castellanos
Jose Maria Moraleda
Ana Maria García-Hernández
Francisco S. Lozano
Fermin Sanchez-Guijo
Eva María Villarón
Miriam Lopez Parra
Rosa María Yañez
Antonio de la Cuesta Diaz
Juan Rigoberto Tejedo
Francisco J. Bedoya
Franz Martin
Manuel Miralles
Lourdes del Rio Sola
María Eugenia Fernández-Santos
José Manuel Ligero
Francisco Morant
Luis Hernández-Blasco
Etelvina Andreu
Abdelkrim Hmadcha
Damian Garcia-Olmo
Bernat Soria
Trials, 22
[47] Phase I/II Trial of Liver-derived Mesenchymal Stem Cells in Pediatric Liver-based Metabolic Disorders: A Prospective, Open Label, Multicenter, Partially Randomized, Safety Study of One Cycle of Heterologous Human Adult Liver-derived Progenitor Cells (HepaStem) in Urea Cycle Disorders and Crigler-Najjar Syndrome Patients
Smets, Francoise
Dobbelaere, Dries
McKiernan, Patrick
Dionisi-Vici, Carlo
Broue, Pierre
Jacquemin, Emmanuel
Lopes, Ana Isabel
Goncalves, Isabel
Mandel, Hanna
Pawlowska, Joanna
Kaminska, Diana
Shteyer, Eyal
Torre, Giuliano
Shapiro, Riki
Eyskens, Francois
Clapuyt, Philippe
Gissen, Paul
Pariente, Daniele
Grunewald, Stephanie
Yudkoff, Marc
Binda, Maria Mercedes
Najimi, Mustapha
Belmonte, Nathalie
de Vos, Beatrice
Thonnard, Joelle
Sokal, Etienne
TRANSPLANTATION, 2019, 103 (09) : 1903 - 1915
[48] Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial
Yamahara, Kenichi
Hamada, Akiko
Soma, Toshihiro
Okamoto, Rika
Okada, Masaya
Yoshihara, Satoshi
Yoshihara, Kyoko
Ikegame, Kazuhiro
Tamaki, Hiroya
Kaida, Katsuji
Inoue, Takayuki
Ohsugi, Yuko
Nishikawa, Hiroki
Hayashi, Hiroshi
Ito, Yoichi M.
Iijima, Hiroaki
Ohnishi, Shunsuke
Hashimoto, Daigo
Isoe, Toshiyuki
Teshima, Takanori
Ogawa, Hiroyasu
Sato, Norihiro
Fujimori, Yoshihiro
BMJ OPEN, 2019, 9 (07):

← 1 2 3 4 5 →